Predictive value of bile acids as metabolite biomarkers for gallstone disease: A systematic review and meta-analysis
The profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern. This study aims to characterize the variation of the BA profiles in GSD patients, thereby to discover the potential metabolite biomarkers for earlier de...
Saved in:
| Published in | PloS one Vol. 19; no. 7; p. e0305170 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
25.07.2024
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern. This study aims to characterize the variation of the BA profiles in GSD patients, thereby to discover the potential metabolite biomarkers for earlier detection of GSD.
Literature search of eight electronic database in both English and Chinese was completed on May 11, 2023. The qualitative and quantitative reviews were performed to summarize the changes of BA profiles in GSD patients compared with healthy subjects. The concentrations of BAs were adopted as the primary outcomes and the weighted mean differences (WMDs) and 95% confidence interval (CI) were generated by random-effects meta-analysis models.
A total of 30 studies were enrolled which included 2313 participants and reported the 39 BAs or their ratios. Qualitative review demonstrated serum Taurocholic Acid (TCA), Glycochenodeoxycholic acid (GCDCA), Glycocholic acid (GCA), Taurochenodeoxycholic acid (TCDCA), Glycodeoxycholic acid (GDCA) and Deoxycholic acid (DCA) were significantly increased in GSD patients compared with healthy subjects. Meta analysis was performed in 16 studies and showed that serum Total BAs (TBA) (WMD = 1.36μmol/L, 95%CI = 0.33; 2.4) was elevated however bile TBA (WMD = -36.96mmol/L, 95%CI = -52.32; -21.6) was declined in GSD patients. GCA (WMD = 0.83μmol/L, 95%CI = 0.06; 1.6) and TCA (WMD = 0.51μmol/L; 95%CI = 0.18; 0.85) were both increased in serum sample; TCDCA (WMD = 2.64mmol/L, 95%CI = 0.16; 5.12) was rising, however GCDCA (WMD = -13.82mmol/L, 95%CI = -21.86; -5.78) was falling in bile sample of GSD patients. The level of serum DCA in the GSD patients was found to be increased by using chromatography, yet decreased by chromatography mass spectrometry.
The profiles of BAs demonstrated distinctive changes in GSD patients compared with healthy control subjects. Serum GCA, TCA and GCDCA, as the typically variant BAs, presented as a potential marker for earlier diagnosis of GSD, which could facilitate early prophylactic intervention. Yet, further validation of these biomarkers by longitudinal studies is still warranted in the future. PROSPERO registration number CRD42022339649. |
|---|---|
| AbstractList | The profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern. This study aims to characterize the variation of the BA profiles in GSD patients, thereby to discover the potential metabolite biomarkers for earlier detection of GSD.BACKGROUNDThe profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern. This study aims to characterize the variation of the BA profiles in GSD patients, thereby to discover the potential metabolite biomarkers for earlier detection of GSD.Literature search of eight electronic database in both English and Chinese was completed on May 11, 2023. The qualitative and quantitative reviews were performed to summarize the changes of BA profiles in GSD patients compared with healthy subjects. The concentrations of BAs were adopted as the primary outcomes and the weighted mean differences (WMDs) and 95% confidence interval (CI) were generated by random-effects meta-analysis models.METHODSLiterature search of eight electronic database in both English and Chinese was completed on May 11, 2023. The qualitative and quantitative reviews were performed to summarize the changes of BA profiles in GSD patients compared with healthy subjects. The concentrations of BAs were adopted as the primary outcomes and the weighted mean differences (WMDs) and 95% confidence interval (CI) were generated by random-effects meta-analysis models.A total of 30 studies were enrolled which included 2313 participants and reported the 39 BAs or their ratios. Qualitative review demonstrated serum Taurocholic Acid (TCA), Glycochenodeoxycholic acid (GCDCA), Glycocholic acid (GCA), Taurochenodeoxycholic acid (TCDCA), Glycodeoxycholic acid (GDCA) and Deoxycholic acid (DCA) were significantly increased in GSD patients compared with healthy subjects. Meta analysis was performed in 16 studies and showed that serum Total BAs (TBA) (WMD = 1.36μmol/L, 95%CI = 0.33; 2.4) was elevated however bile TBA (WMD = -36.96mmol/L, 95%CI = -52.32; -21.6) was declined in GSD patients. GCA (WMD = 0.83μmol/L, 95%CI = 0.06; 1.6) and TCA (WMD = 0.51μmol/L; 95%CI = 0.18; 0.85) were both increased in serum sample; TCDCA (WMD = 2.64mmol/L, 95%CI = 0.16; 5.12) was rising, however GCDCA (WMD = -13.82mmol/L, 95%CI = -21.86; -5.78) was falling in bile sample of GSD patients. The level of serum DCA in the GSD patients was found to be increased by using chromatography, yet decreased by chromatography mass spectrometry.RESULTSA total of 30 studies were enrolled which included 2313 participants and reported the 39 BAs or their ratios. Qualitative review demonstrated serum Taurocholic Acid (TCA), Glycochenodeoxycholic acid (GCDCA), Glycocholic acid (GCA), Taurochenodeoxycholic acid (TCDCA), Glycodeoxycholic acid (GDCA) and Deoxycholic acid (DCA) were significantly increased in GSD patients compared with healthy subjects. Meta analysis was performed in 16 studies and showed that serum Total BAs (TBA) (WMD = 1.36μmol/L, 95%CI = 0.33; 2.4) was elevated however bile TBA (WMD = -36.96mmol/L, 95%CI = -52.32; -21.6) was declined in GSD patients. GCA (WMD = 0.83μmol/L, 95%CI = 0.06; 1.6) and TCA (WMD = 0.51μmol/L; 95%CI = 0.18; 0.85) were both increased in serum sample; TCDCA (WMD = 2.64mmol/L, 95%CI = 0.16; 5.12) was rising, however GCDCA (WMD = -13.82mmol/L, 95%CI = -21.86; -5.78) was falling in bile sample of GSD patients. The level of serum DCA in the GSD patients was found to be increased by using chromatography, yet decreased by chromatography mass spectrometry.The profiles of BAs demonstrated distinctive changes in GSD patients compared with healthy control subjects. Serum GCA, TCA and GCDCA, as the typically variant BAs, presented as a potential marker for earlier diagnosis of GSD, which could facilitate early prophylactic intervention. Yet, further validation of these biomarkers by longitudinal studies is still warranted in the future. PROSPERO registration number CRD42022339649.CONCLUSIONThe profiles of BAs demonstrated distinctive changes in GSD patients compared with healthy control subjects. Serum GCA, TCA and GCDCA, as the typically variant BAs, presented as a potential marker for earlier diagnosis of GSD, which could facilitate early prophylactic intervention. Yet, further validation of these biomarkers by longitudinal studies is still warranted in the future. PROSPERO registration number CRD42022339649. Background The profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern. This study aims to characterize the variation of the BA profiles in GSD patients, thereby to discover the potential metabolite biomarkers for earlier detection of GSD. Methods Literature search of eight electronic database in both English and Chinese was completed on May 11, 2023. The qualitative and quantitative reviews were performed to summarize the changes of BA profiles in GSD patients compared with healthy subjects. The concentrations of BAs were adopted as the primary outcomes and the weighted mean differences (WMDs) and 95% confidence interval (CI) were generated by random-effects meta-analysis models. Results A total of 30 studies were enrolled which included 2313 participants and reported the 39 BAs or their ratios. Qualitative review demonstrated serum Taurocholic Acid (TCA), Glycochenodeoxycholic acid (GCDCA), Glycocholic acid (GCA), Taurochenodeoxycholic acid (TCDCA), Glycodeoxycholic acid (GDCA) and Deoxycholic acid (DCA) were significantly increased in GSD patients compared with healthy subjects. Meta analysis was performed in 16 studies and showed that serum Total BAs (TBA) (WMD = 1.36[mu]mol/L, 95%CI = 0.33; 2.4) was elevated however bile TBA (WMD = -36.96mmol/L, 95%CI = -52.32; -21.6) was declined in GSD patients. GCA (WMD = 0.83[mu]mol/L, 95%CI = 0.06; 1.6) and TCA (WMD = 0.51[mu]mol/L; 95%CI = 0.18; 0.85) were both increased in serum sample; TCDCA (WMD = 2.64mmol/L, 95%CI = 0.16; 5.12) was rising, however GCDCA (WMD = -13.82mmol/L, 95%CI = -21.86; -5.78) was falling in bile sample of GSD patients. The level of serum DCA in the GSD patients was found to be increased by using chromatography, yet decreased by chromatography mass spectrometry. Conclusion The profiles of BAs demonstrated distinctive changes in GSD patients compared with healthy control subjects. Serum GCA, TCA and GCDCA, as the typically variant BAs, presented as a potential marker for earlier diagnosis of GSD, which could facilitate early prophylactic intervention. Yet, further validation of these biomarkers by longitudinal studies is still warranted in the future. PROSPERO registration number CRD42022339649. The profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern. This study aims to characterize the variation of the BA profiles in GSD patients, thereby to discover the potential metabolite biomarkers for earlier detection of GSD. Literature search of eight electronic database in both English and Chinese was completed on May 11, 2023. The qualitative and quantitative reviews were performed to summarize the changes of BA profiles in GSD patients compared with healthy subjects. The concentrations of BAs were adopted as the primary outcomes and the weighted mean differences (WMDs) and 95% confidence interval (CI) were generated by random-effects meta-analysis models. A total of 30 studies were enrolled which included 2313 participants and reported the 39 BAs or their ratios. Qualitative review demonstrated serum Taurocholic Acid (TCA), Glycochenodeoxycholic acid (GCDCA), Glycocholic acid (GCA), Taurochenodeoxycholic acid (TCDCA), Glycodeoxycholic acid (GDCA) and Deoxycholic acid (DCA) were significantly increased in GSD patients compared with healthy subjects. Meta analysis was performed in 16 studies and showed that serum Total BAs (TBA) (WMD = 1.36[mu]mol/L, 95%CI = 0.33; 2.4) was elevated however bile TBA (WMD = -36.96mmol/L, 95%CI = -52.32; -21.6) was declined in GSD patients. GCA (WMD = 0.83[mu]mol/L, 95%CI = 0.06; 1.6) and TCA (WMD = 0.51[mu]mol/L; 95%CI = 0.18; 0.85) were both increased in serum sample; TCDCA (WMD = 2.64mmol/L, 95%CI = 0.16; 5.12) was rising, however GCDCA (WMD = -13.82mmol/L, 95%CI = -21.86; -5.78) was falling in bile sample of GSD patients. The level of serum DCA in the GSD patients was found to be increased by using chromatography, yet decreased by chromatography mass spectrometry. The profiles of BAs demonstrated distinctive changes in GSD patients compared with healthy control subjects. Serum GCA, TCA and GCDCA, as the typically variant BAs, presented as a potential marker for earlier diagnosis of GSD, which could facilitate early prophylactic intervention. Yet, further validation of these biomarkers by longitudinal studies is still warranted in the future. BackgroundThe profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern. This study aims to characterize the variation of the BA profiles in GSD patients, thereby to discover the potential metabolite biomarkers for earlier detection of GSD.MethodsLiterature search of eight electronic database in both English and Chinese was completed on May 11, 2023. The qualitative and quantitative reviews were performed to summarize the changes of BA profiles in GSD patients compared with healthy subjects. The concentrations of BAs were adopted as the primary outcomes and the weighted mean differences (WMDs) and 95% confidence interval (CI) were generated by random-effects meta-analysis models.ResultsA total of 30 studies were enrolled which included 2313 participants and reported the 39 BAs or their ratios. Qualitative review demonstrated serum Taurocholic Acid (TCA), Glycochenodeoxycholic acid (GCDCA), Glycocholic acid (GCA), Taurochenodeoxycholic acid (TCDCA), Glycodeoxycholic acid (GDCA) and Deoxycholic acid (DCA) were significantly increased in GSD patients compared with healthy subjects. Meta analysis was performed in 16 studies and showed that serum Total BAs (TBA) (WMD = 1.36μmol/L, 95%CI = 0.33; 2.4) was elevated however bile TBA (WMD = -36.96mmol/L, 95%CI = -52.32; -21.6) was declined in GSD patients. GCA (WMD = 0.83μmol/L, 95%CI = 0.06; 1.6) and TCA (WMD = 0.51μmol/L; 95%CI = 0.18; 0.85) were both increased in serum sample; TCDCA (WMD = 2.64mmol/L, 95%CI = 0.16; 5.12) was rising, however GCDCA (WMD = -13.82mmol/L, 95%CI = -21.86; -5.78) was falling in bile sample of GSD patients. The level of serum DCA in the GSD patients was found to be increased by using chromatography, yet decreased by chromatography mass spectrometry.ConclusionThe profiles of BAs demonstrated distinctive changes in GSD patients compared with healthy control subjects. Serum GCA, TCA and GCDCA, as the typically variant BAs, presented as a potential marker for earlier diagnosis of GSD, which could facilitate early prophylactic intervention. Yet, further validation of these biomarkers by longitudinal studies is still warranted in the future. PROSPERO registration number CRD42022339649. The profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern. This study aims to characterize the variation of the BA profiles in GSD patients, thereby to discover the potential metabolite biomarkers for earlier detection of GSD. Literature search of eight electronic database in both English and Chinese was completed on May 11, 2023. The qualitative and quantitative reviews were performed to summarize the changes of BA profiles in GSD patients compared with healthy subjects. The concentrations of BAs were adopted as the primary outcomes and the weighted mean differences (WMDs) and 95% confidence interval (CI) were generated by random-effects meta-analysis models. A total of 30 studies were enrolled which included 2313 participants and reported the 39 BAs or their ratios. Qualitative review demonstrated serum Taurocholic Acid (TCA), Glycochenodeoxycholic acid (GCDCA), Glycocholic acid (GCA), Taurochenodeoxycholic acid (TCDCA), Glycodeoxycholic acid (GDCA) and Deoxycholic acid (DCA) were significantly increased in GSD patients compared with healthy subjects. Meta analysis was performed in 16 studies and showed that serum Total BAs (TBA) (WMD = 1.36μmol/L, 95%CI = 0.33; 2.4) was elevated however bile TBA (WMD = -36.96mmol/L, 95%CI = -52.32; -21.6) was declined in GSD patients. GCA (WMD = 0.83μmol/L, 95%CI = 0.06; 1.6) and TCA (WMD = 0.51μmol/L; 95%CI = 0.18; 0.85) were both increased in serum sample; TCDCA (WMD = 2.64mmol/L, 95%CI = 0.16; 5.12) was rising, however GCDCA (WMD = -13.82mmol/L, 95%CI = -21.86; -5.78) was falling in bile sample of GSD patients. The level of serum DCA in the GSD patients was found to be increased by using chromatography, yet decreased by chromatography mass spectrometry. The profiles of BAs demonstrated distinctive changes in GSD patients compared with healthy control subjects. Serum GCA, TCA and GCDCA, as the typically variant BAs, presented as a potential marker for earlier diagnosis of GSD, which could facilitate early prophylactic intervention. Yet, further validation of these biomarkers by longitudinal studies is still warranted in the future. PROSPERO registration number CRD42022339649. Background The profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern. This study aims to characterize the variation of the BA profiles in GSD patients, thereby to discover the potential metabolite biomarkers for earlier detection of GSD. Methods Literature search of eight electronic database in both English and Chinese was completed on May 11, 2023. The qualitative and quantitative reviews were performed to summarize the changes of BA profiles in GSD patients compared with healthy subjects. The concentrations of BAs were adopted as the primary outcomes and the weighted mean differences (WMDs) and 95% confidence interval (CI) were generated by random-effects meta-analysis models. Results A total of 30 studies were enrolled which included 2313 participants and reported the 39 BAs or their ratios. Qualitative review demonstrated serum Taurocholic Acid (TCA), Glycochenodeoxycholic acid (GCDCA), Glycocholic acid (GCA), Taurochenodeoxycholic acid (TCDCA), Glycodeoxycholic acid (GDCA) and Deoxycholic acid (DCA) were significantly increased in GSD patients compared with healthy subjects. Meta analysis was performed in 16 studies and showed that serum Total BAs (TBA) (WMD = 1.36μmol/L, 95%CI = 0.33; 2.4) was elevated however bile TBA (WMD = -36.96mmol/L, 95%CI = -52.32; -21.6) was declined in GSD patients. GCA (WMD = 0.83μmol/L, 95%CI = 0.06; 1.6) and TCA (WMD = 0.51μmol/L; 95%CI = 0.18; 0.85) were both increased in serum sample; TCDCA (WMD = 2.64mmol/L, 95%CI = 0.16; 5.12) was rising, however GCDCA (WMD = -13.82mmol/L, 95%CI = -21.86; -5.78) was falling in bile sample of GSD patients. The level of serum DCA in the GSD patients was found to be increased by using chromatography, yet decreased by chromatography mass spectrometry. Conclusion The profiles of BAs demonstrated distinctive changes in GSD patients compared with healthy control subjects. Serum GCA, TCA and GCDCA, as the typically variant BAs, presented as a potential marker for earlier diagnosis of GSD, which could facilitate early prophylactic intervention. Yet, further validation of these biomarkers by longitudinal studies is still warranted in the future. PROSPERO registration number CRD42022339649. |
| Audience | Academic |
| Author | Jiang, Miao Zhao, Ning Wu, Yingnan Gu, Hao Wang, Juan Han, Xu Liao, Xing |
| AuthorAffiliation | 1 Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China Sapporo Medical University, JAPAN 2 Department of Traditional Chinese Medicine, Inner Mongolia People’s Hospital, Hohhot, China |
| AuthorAffiliation_xml | – name: 1 Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China – name: Sapporo Medical University, JAPAN – name: 2 Department of Traditional Chinese Medicine, Inner Mongolia People’s Hospital, Hohhot, China |
| Author_xml | – sequence: 1 givenname: Xu surname: Han fullname: Han, Xu – sequence: 2 givenname: Juan surname: Wang fullname: Wang, Juan – sequence: 3 givenname: Yingnan surname: Wu fullname: Wu, Yingnan – sequence: 4 givenname: Hao surname: Gu fullname: Gu, Hao – sequence: 5 givenname: Ning surname: Zhao fullname: Zhao, Ning – sequence: 6 givenname: Xing surname: Liao fullname: Liao, Xing – sequence: 7 givenname: Miao orcidid: 0000-0002-3681-9494 surname: Jiang fullname: Jiang, Miao |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39052638$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk1trFDEUxwep2It-A9GAIPqwazKZyUz6IqV4KRQq3l7DmeTMNjU7qUlmtd_ebHcq3VJE5iFD8vv_zyU5-8XO4AcsiqeMzhlv2JsLP4YB3Pwyb88ppzVr6INij0lezkRJ-c6t_91iP8YLSmveCvGo2OWS1qXg7V6RPgU0Vie7QrICNyLxPemsQwLamkggkiUm6LyzCfOBX0L4gSGS3geyAOdiyvGJsREh4iE5IvEqJlxCspoEXFn8RWAw1yYzyPleRRsfFw97cBGfTOtB8e39u6_HH2enZx9Ojo9OZ1pInmatMH3dd3XDaWlYTSUXzNCONb3pTallD1K2TBqJ2gBHZkTdSVp1tJEUKSA_KJ5vfC-dj2pqWFSctlXDSkZFJk42hPFwoS6DzeVdKQ9WXW_4sFAQcikOlay6tquAU2xFVVHR1X1LG10ZgyAryrPX2yna2C3RaBxSALdlun0y2HO18CvFWNkwee3wanII_ueIMamljRqdgwH9OCXe8FqsE39xB72_vInKN4XKDr3PgfXaVB21tKylaEWbqfk9VP4MLq3O19vn97AteL0lyEzC32kBY4zq5Mvn_2fPvm-zL2-x5wgunUfvxmT9ELfBZ7db_bfHN-86A4cbQAcfY8BeaZtg7ZNLs04xqtZDdNM0tR4iNQ1RFld3xDf-_5T9AZ5VISI |
| CitedBy_id | crossref_primary_10_1002_imt2_70000 |
| Cites_doi | 10.1002/hep.29371 10.1136/bmj.315.7109.629 10.1053/gast.2000.16495 10.1038/nm1138 10.3748/wjg.v4.i1.82 10.1016/j.gtc.2010.02.007 10.1016/S0889-8553(21)00532-X 10.3748/wjg.v20.i40.14942 10.1186/1471-2288-14-135 10.1111/den.14379 10.1016/j.jhep.2019.06.011 10.1186/1476-511X-12-67 10.1194/jlr.M600282-JLR200 10.1136/bmj.n71 10.3389/fphar.2018.00939 10.1016/j.ejphar.2021.174376 10.3390/nu13041104 10.1194/jlr.M800162-JLR200 10.1002/cphy.c120023 10.1126/science.1070477 10.3390/molecules27061983 10.1016/j.jhep.2016.03.005 10.1172/JCI0215387 10.1136/gut.48.5.702 10.1172/JCI115961 10.1038/s41467-021-27758-8 10.1016/j.surge.2018.04.001 10.1002/cphy.c120027 10.1186/s12876-020-01512-8 10.1053/j.gastro.2021.10.017 10.1007/s12072-021-10231-5 10.12659/MSM.915984 10.1124/dmd.108.025155 10.1177/2050640614527938 10.1074/jbc.M109.010173 10.1016/j.metabol.2021.154728 10.1038/s41467-018-07460-y 10.1016/S0140-6736(06)69044-2 10.1007/s10654-010-9491-z 10.1002/jsfa.12222 10.1136/bmj.d4002 10.1038/nrgastro.2017.119 10.1016/S0022-2275(20)39696-6 10.1586/17474124.2016.1109445 10.1177/0962280216669183 10.1194/jlr.S091199 10.1001/jama.2022.2350 10.1021/pr500920q 10.1080/17474124.2019.1549988 10.1111/1758-2229.12319 10.1128/spectrum.00518-22 10.1152/ajpgi.00385.2019 10.1053/gast.1996.v111.pm8780583 10.1152/ajpgi.00308.2020 10.1097/00042737-200506000-00007 10.3389/fphar.2020.00012 10.1074/jbc.M209525200 10.1186/s40168-019-0712-8 10.1080/05704928.2016.1167707 10.1002/jrsm.1429 10.1186/1477-7819-9-164 10.1002/hep.21942 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2024 Han et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2024 Public Library of Science 2024 Han et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 Han et al 2024 Han et al 2024 Han et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: Copyright: © 2024 Han et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2024 Public Library of Science – notice: 2024 Han et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 Han et al 2024 Han et al – notice: 2024 Han et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0305170 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest SciTech Premium Collection Technology Collection Materials Science & Engineering Database ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Agricultural Science Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | Bile acids as metabolite biomarkers for gallstone disease |
| EISSN | 1932-6203 |
| ExternalDocumentID | 3084712106 oai_doaj_org_article_94b8b4a30e864406b5f807c4ddea9403 PMC11271903 A802596868 39052638 10_1371_journal_pone_0305170 |
| Genre | Meta-Analysis Systematic Review Journal Article |
| GeographicLocations | China California |
| GeographicLocations_xml | – name: China – name: California |
| GrantInformation_xml | – fundername: ; grantid: 81873181 – fundername: ; grantid: Z0852 – fundername: ; grantid: Z0742 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. ADRAZ BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 5PM PUEGO ESTFP |
| ID | FETCH-LOGICAL-c693t-86df5fb57302d1509361d0b17fdfd2c9fa99819d9ecda3e1d65b904b0790e0ae3 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Thu Nov 28 02:59:17 EST 2024 Wed Aug 27 01:20:28 EDT 2025 Thu Aug 21 18:34:13 EDT 2025 Tue Aug 05 11:24:53 EDT 2025 Fri Jul 25 10:28:42 EDT 2025 Tue Jun 17 22:06:23 EDT 2025 Tue Jun 10 21:07:30 EDT 2025 Fri Jun 27 05:56:24 EDT 2025 Fri Jun 27 05:27:27 EDT 2025 Thu May 22 21:24:30 EDT 2025 Wed Feb 19 02:05:37 EST 2025 Thu Apr 24 23:07:51 EDT 2025 Tue Jul 01 00:42:16 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| License | Copyright: © 2024 Han et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c693t-86df5fb57302d1509361d0b17fdfd2c9fa99819d9ecda3e1d65b904b0790e0ae3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Competing Interests: The authors have declared that no competing interests exist. |
| ORCID | 0000-0002-3681-9494 |
| OpenAccessLink | https://doaj.org/article/94b8b4a30e864406b5f807c4ddea9403 |
| PMID | 39052638 |
| PQID | 3084712106 |
| PQPubID | 1436336 |
| PageCount | e0305170 |
| ParticipantIDs | plos_journals_3084712106 doaj_primary_oai_doaj_org_article_94b8b4a30e864406b5f807c4ddea9403 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11271903 proquest_miscellaneous_3084773566 proquest_journals_3084712106 gale_infotracmisc_A802596868 gale_infotracacademiconefile_A802596868 gale_incontextgauss_ISR_A802596868 gale_incontextgauss_IOV_A802596868 gale_healthsolutions_A802596868 pubmed_primary_39052638 crossref_citationtrail_10_1371_journal_pone_0305170 crossref_primary_10_1371_journal_pone_0305170 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-07-25 |
| PublicationDateYYYYMMDD | 2024-07-25 |
| PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-25 day: 25 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2024 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | M Makishima (pone.0305170.ref079) 2002; 296 AR Alvi (pone.0305170.ref007) 2011; 9 A Di Ciaula (pone.0305170.ref009) 2019; 13 CR Pullinger (pone.0305170.ref067) 2002; 110 DW Hay (pone.0305170.ref036) 1993; 34 F Berr (pone.0305170.ref065) 1992; 90 C Jinpeng (pone.0305170.ref048) 2003; 23 M Egger (pone.0305170.ref027) 1997; 315 J Isherwood (pone.0305170.ref012) 2019; 17 D Luo (pone.0305170.ref024) 2018; 27 pone.0305170.ref046 pone.0305170.ref045 S Al-Dury (pone.0305170.ref080) 2019; 71 L Shaogao (pone.0305170.ref054) 1990; 007 M Xueping (pone.0305170.ref052) 1995 pone.0305170.ref042 MD Thompson (pone.0305170.ref015) 2018; 67 M Fracchia (pone.0305170.ref032) 2001; 48 pone.0305170.ref041 Z Hao (pone.0305170.ref028) 2022; 16 Y Xie (pone.0305170.ref068) 2009; 284 X Hu (pone.0305170.ref078) 2013; 12 T Rabenstein (pone.0305170.ref014) 2005; 17 C Xie (pone.0305170.ref016) 2021; 13 L Liu (pone.0305170.ref017) 2020; 11 JY Chiang (pone.0305170.ref058) 2013; 3 Z Chunhua (pone.0305170.ref050) 1999 JR Gallaher (pone.0305170.ref005) 2022; 327 J Shi (pone.0305170.ref023) 2020; 11 LA Thomas (pone.0305170.ref033) 2000; 119 S Han (pone.0305170.ref069) 2009; 37 S Mukai (pone.0305170.ref006) 2023; 35 pone.0305170.ref039 E Ferkingstad (pone.0305170.ref071) 2018; 9 Z Kang (pone.0305170.ref001) 2019; 25 W Wenjuan (pone.0305170.ref044) 2016; 39 G Xie (pone.0305170.ref084) 2015; 14 P Portincasa (pone.0305170.ref004) 2006; 368 Z Zhang (pone.0305170.ref081) 2021; 118 W Jia (pone.0305170.ref066) 2018; 15 MJ Page (pone.0305170.ref021) 2021; 372 JA Sterne (pone.0305170.ref026) 2011; 343 T Saixiong (pone.0305170.ref053) 1992 TQ Han (pone.0305170.ref035) 1998; 4 M Wenjie (pone.0305170.ref043) 2018; 25 J Cai (pone.0305170.ref061) 2022; 108238 J Pauletzki (pone.0305170.ref013) 1996; 111 J Suli (pone.0305170.ref038) 2022; 19 W. Zhibo (pone.0305170.ref040) 2020; 10 O Renner (pone.0305170.ref072) 2014; 2 L Zhu (pone.0305170.ref002) 2014; 20 H Ko (pone.0305170.ref020) 2016; 51 HH Wang (pone.0305170.ref060) 2010; 39 AF Peery (pone.0305170.ref008) 2022; 162 H Hu (pone.0305170.ref075) 2022; 13 (EASL) EAftSotL (pone.0305170.ref010) 2016; 65 M Rudling (pone.0305170.ref064) 2019; 60 G Lambert (pone.0305170.ref083) 2003; 278 TM Sarenac (pone.0305170.ref057) 2018; 9 J Cai (pone.0305170.ref019) 2020; 319 Y Shulpekova (pone.0305170.ref056) 2022; 27 W Xu (pone.0305170.ref077) 2023; 103 N Keren (pone.0305170.ref031) 2015; 7 M Bin (pone.0305170.ref047) 2005; 17 X Ye (pone.0305170.ref076) 2022; 10 P Portincasa (pone.0305170.ref011) 2016; 10 S Rejchrt (pone.0305170.ref029) 2019 X Wan (pone.0305170.ref025) 2014; 14 A Mamianetti (pone.0305170.ref034) 1999; 59 S E (pone.0305170.ref003) 2021; 908 A. Stang (pone.0305170.ref022) 2010; 25 JL Boyer (pone.0305170.ref059) 2013; 3 T Li (pone.0305170.ref070) 2007; 48 MM Fisher (pone.0305170.ref037) 1973; 109 D Zhiyong (pone.0305170.ref051) 1997 O Renner (pone.0305170.ref073) 2008; 49 C Dayi (pone.0305170.ref049) 2001 M Bertolotti (pone.0305170.ref063) 2007; 46 pone.0305170.ref055 AD Cooper (pone.0305170.ref062) 1991; 20 L Wu (pone.0305170.ref018) 2020; 20 IP van de Peppel (pone.0305170.ref074) 2020; 319 A Moschetta (pone.0305170.ref082) 2004; 10 N Molinero (pone.0305170.ref030) 2019; 7 |
| References_xml | – volume: 67 start-page: 955 issue: 3 year: 2018 ident: pone.0305170.ref015 article-title: beta-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis publication-title: Hepatology doi: 10.1002/hep.29371 – volume: 315 start-page: 629 issue: 7109 year: 1997 ident: pone.0305170.ref027 article-title: Bias in meta-analysis detected by a simple, graphical test publication-title: BMJ doi: 10.1136/bmj.315.7109.629 – volume: 119 start-page: 806 issue: 3 year: 2000 ident: pone.0305170.ref033 article-title: Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis publication-title: Gastroenterology doi: 10.1053/gast.2000.16495 – volume: 10 start-page: 1352 issue: 12 year: 2004 ident: pone.0305170.ref082 article-title: Prevention of cholesterol gallstone disease by FXR agonists in a mouse model publication-title: Nat Med doi: 10.1038/nm1138 – volume: 39 start-page: 403 issue: 04 year: 2016 ident: pone.0305170.ref044 article-title: The value of analysis on conjugated bile acids in biliary tract cancer publication-title: Journal of Zunyi Medical University – volume: 4 start-page: 82 issue: 1 year: 1998 ident: pone.0305170.ref035 article-title: Bile acids in serum and bile of patients with cholesterol gallstone publication-title: World J Gastroenterol doi: 10.3748/wjg.v4.i1.82 – volume: 39 start-page: 185vii issue: 2 year: 2010 ident: pone.0305170.ref060 article-title: Lith genes and genetic analysis of cholesterol gallstone formation publication-title: Gastroenterol Clin North Am doi: 10.1016/j.gtc.2010.02.007 – volume: 20 start-page: 21 issue: 1 year: 1991 ident: pone.0305170.ref062 article-title: Metabolic basis of cholesterol gallstone disease publication-title: Gastroenterol Clin North Am doi: 10.1016/S0889-8553(21)00532-X – volume: 109 start-page: 190 issue: 3 year: 1973 ident: pone.0305170.ref037 article-title: Sex differences in the bile acid composition of human bile: studies in patients with and without gallstones publication-title: Canadian Medical Association journal – volume: 19 start-page: 165 issue: 13 year: 2022 ident: pone.0305170.ref038 article-title: Detection and analysis of serum bile acid spectrum in patients with cholelithiasis publication-title: China Medical Herald | Chin Med Herald – volume: 20 start-page: 14942 issue: 40 year: 2014 ident: pone.0305170.ref002 article-title: Prevalence of and risk factors for gallstones in Uighur and Han Chinese publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i40.14942 – volume: 14 start-page: 135 year: 2014 ident: pone.0305170.ref025 article-title: Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-135 – volume: 35 start-page: 47 year: 2023 ident: pone.0305170.ref006 article-title: Urgent and emergency endoscopic retrograde cholangiopancreatography for gallstone-induced acute cholangitis and pancreatitis publication-title: Dig Endosc doi: 10.1111/den.14379 – volume: 71 start-page: 986 issue: 5 year: 2019 ident: pone.0305170.ref080 article-title: Obeticholic acid may increase the risk of gallstone formation in susceptible patients publication-title: J Hepatol doi: 10.1016/j.jhep.2019.06.011 – volume: 12 start-page: 67 year: 2013 ident: pone.0305170.ref078 article-title: Effects of NS Lactobacillus strains on lipid metabolism of rats fed a high-cholesterol diet publication-title: Lipids in health and disease doi: 10.1186/1476-511X-12-67 – start-page: 55 issue: 01 year: 2001 ident: pone.0305170.ref049 article-title: Analysis and Clinical Application of serum conjugated bile acids in cholecystolithiasis publication-title: Journal of Clinical Hepatol – volume: 48 start-page: 373 issue: 2 year: 2007 ident: pone.0305170.ref070 article-title: PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine publication-title: J Lipid Res doi: 10.1194/jlr.M600282-JLR200 – ident: pone.0305170.ref046 – volume: 372 start-page: n71 year: 2021 ident: pone.0305170.ref021 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ doi: 10.1136/bmj.n71 – volume: 9 start-page: 939 year: 2018 ident: pone.0305170.ref057 article-title: Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients publication-title: Front Pharmacol doi: 10.3389/fphar.2018.00939 – volume: 908 start-page: 174376 year: 2021 ident: pone.0305170.ref003 article-title: Recent advances, novel targets and treatments for cholelithiasis; a narrative review publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2021.174376 – ident: pone.0305170.ref042 – volume: 13 start-page: 1104 issue: 4 year: 2021 ident: pone.0305170.ref016 article-title: Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease publication-title: Nutrients doi: 10.3390/nu13041104 – start-page: 60 issue: 02 year: 1999 ident: pone.0305170.ref050 article-title: Serum bile acid analysis of fatty liver and cholelithiasis publication-title: Chinese Journal of Digestion – start-page: 298 issue: 06 year: 1995 ident: pone.0305170.ref052 article-title: Determination and clinical significance of serum and bile bile acids in patients with gallstones by high performance liquid chromatography publication-title: Journal of Clinical Surgery – volume: 49 start-page: 2045 issue: 9 year: 2008 ident: pone.0305170.ref073 article-title: Reduced ileal expression of OSTalpha-OSTbeta in non-obese gallstone disease publication-title: J Lipid Res doi: 10.1194/jlr.M800162-JLR200 – volume: 3 start-page: 1191 issue: 3 year: 2013 ident: pone.0305170.ref058 article-title: Bile acid metabolism and signaling publication-title: Compr Physiol doi: 10.1002/cphy.c120023 – volume: 296 start-page: 1313 issue: 5571 year: 2002 ident: pone.0305170.ref079 article-title: Vitamin D receptor as an intestinal bile acid sensor publication-title: Science doi: 10.1126/science.1070477 – volume: 27 issue: 6 year: 2022 ident: pone.0305170.ref056 article-title: A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling publication-title: Molecules (Basel, Switzerland) doi: 10.3390/molecules27061983 – volume: 65 start-page: 146 issue: 1 year: 2016 ident: pone.0305170.ref010 article-title: EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones publication-title: J Hepatol doi: 10.1016/j.jhep.2016.03.005 – volume: 007 start-page: 178 issue: 4 year: 1990 ident: pone.0305170.ref054 article-title: Quantitative analysis of conjugated bile acids in bile by high performance liquid chromatography publication-title: Chinese Journal of Experimental Surgery – volume: 10 start-page: 157 issue: 05 year: 2020 ident: pone.0305170.ref040 article-title: Analysis of results of high-performance liquid chromatography fluorescence determination and mass spectrometry identification of bile acids in serum publication-title: China Medicine and Pharmacy – volume: 110 start-page: 109 issue: 1 year: 2002 ident: pone.0305170.ref067 article-title: Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype publication-title: J Clin Invest doi: 10.1172/JCI0215387 – volume: 48 start-page: 702 issue: 5 year: 2001 ident: pone.0305170.ref032 article-title: Biliary lipid composition in cholesterol microlithiasis publication-title: Gut doi: 10.1136/gut.48.5.702 – volume: 108238 year: 2022 ident: pone.0305170.ref061 article-title: Bile acid metabolism and signaling, the microbiota, and metabolic disease publication-title: Pharmacol Ther – volume: 90 start-page: 859 issue: 3 year: 1992 ident: pone.0305170.ref065 article-title: Disorders of bile acid metabolism in cholesterol gallstone disease publication-title: J Clin Invest doi: 10.1172/JCI115961 – volume: 13 start-page: 252 issue: 1 year: 2022 ident: pone.0305170.ref075 article-title: Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion publication-title: Nat Commun doi: 10.1038/s41467-021-27758-8 – volume: 17 start-page: 33 issue: 1 year: 2019 ident: pone.0305170.ref012 article-title: A systematic review of the aetiology and management of post cholecystectomy syndrome publication-title: Surgeon doi: 10.1016/j.surge.2018.04.001 – volume: 3 start-page: 1035 issue: 3 year: 2013 ident: pone.0305170.ref059 article-title: Bile formation and secretion publication-title: Compr Physiol doi: 10.1002/cphy.c120027 – volume: 20 start-page: 363 issue: 1 year: 2020 ident: pone.0305170.ref018 article-title: Changes in plasma bile acids are associated with gallbladder stones and polyps publication-title: BMC Gastroenterol doi: 10.1186/s12876-020-01512-8 – ident: pone.0305170.ref045 – volume: 162 start-page: 621 issue: 2 year: 2022 ident: pone.0305170.ref008 article-title: Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021 publication-title: Gastroenterology doi: 10.1053/j.gastro.2021.10.017 – volume: 16 start-page: 447 issue: 2 year: 2022 ident: pone.0305170.ref028 article-title: Alterations of gut microbiome and metabolite profiles in choledocholithiasis concurrent with cholangitis publication-title: Hepatology international doi: 10.1007/s12072-021-10231-5 – ident: pone.0305170.ref041 – volume: 25 start-page: 7312 year: 2019 ident: pone.0305170.ref001 article-title: Proteobacteria Acts as a Pathogenic Risk-Factor for Chronic Abdominal Pain and Diarrhea in Post-Cholecystectomy Syndrome Patients: A Gut Microbiome Metabolomics Study publication-title: Med Sci Monit doi: 10.12659/MSM.915984 – start-page: 2019 year: 2019 ident: pone.0305170.ref029 article-title: Investigation of 23 Bile Acids in Liver Bile in Benign and Malignant Biliary Stenosis: A Pilot Study publication-title: Gastroenterology Research and Practice – ident: pone.0305170.ref039 – volume: 37 start-page: 469 issue: 3 year: 2009 ident: pone.0305170.ref069 article-title: Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes publication-title: Drug metabolism and disposition: the biological fate of chemicals doi: 10.1124/dmd.108.025155 – volume: 2 start-page: 216 issue: 3 year: 2014 ident: pone.0305170.ref072 article-title: Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals publication-title: United European Gastroenterol J doi: 10.1177/2050640614527938 – volume: 25 start-page: 401 issue: 04 year: 2018 ident: pone.0305170.ref043 article-title: A preliminary study on metabonomics of amino acid and glucose in patients with gallbladder stones based on nuclear magnetic resonance publication-title: Chinese Journal of Bases and Clinics in General Surgery – volume: 284 start-page: 16860 issue: 25 year: 2009 ident: pone.0305170.ref068 article-title: Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility publication-title: J Biol Chem doi: 10.1074/jbc.M109.010173 – volume: 118 start-page: 154728 year: 2021 ident: pone.0305170.ref081 article-title: Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity publication-title: Metabolism: clinical and experimental doi: 10.1016/j.metabol.2021.154728 – volume: 9 start-page: 5101 issue: 1 year: 2018 ident: pone.0305170.ref071 article-title: Genome-wide association meta-analysis yields 20 loci associated with gallstone disease publication-title: Nat Commun doi: 10.1038/s41467-018-07460-y – volume: 368 start-page: 230 issue: 9531 year: 2006 ident: pone.0305170.ref004 article-title: Cholesterol gallstone disease publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(06)69044-2 – volume: 25 start-page: 603 issue: 9 year: 2010 ident: pone.0305170.ref022 article-title: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses publication-title: Eur J Epidemiol doi: 10.1007/s10654-010-9491-z – volume: 103 start-page: 1283 issue: 3 year: 2023 ident: pone.0305170.ref077 article-title: L-Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism publication-title: Journal of the science of food and agriculture doi: 10.1002/jsfa.12222 – volume: 343 start-page: d4002 year: 2011 ident: pone.0305170.ref026 article-title: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials publication-title: BMJ doi: 10.1136/bmj.d4002 – volume: 15 start-page: 111 issue: 2 year: 2018 ident: pone.0305170.ref066 article-title: Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis publication-title: Nature reviews Gastroenterology & hepatology doi: 10.1038/nrgastro.2017.119 – volume: 34 start-page: 759 issue: 5 year: 1993 ident: pone.0305170.ref036 article-title: Molecular species of lecithins in human gallbladder bile publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)39696-6 – start-page: 81 issue: 04 year: 1997 ident: pone.0305170.ref051 article-title: Determination of eight conjugated bile acids in human bile by reversed-phase high performance liquid chromatographic publication-title: Bulletin of Hunan Medical University – volume: 10 start-page: 93 issue: 1 year: 2016 ident: pone.0305170.ref011 article-title: Management of gallstones and its related complications publication-title: Expert Rev Gastroenterol Hepatol doi: 10.1586/17474124.2016.1109445 – volume: 27 start-page: 1785 issue: 6 year: 2018 ident: pone.0305170.ref024 article-title: Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range publication-title: Stat Methods Med Res doi: 10.1177/0962280216669183 – volume: 60 start-page: 498 issue: 3 year: 2019 ident: pone.0305170.ref064 article-title: Gallbladder bile supersaturated with cholesterol in gallstone patients preferentially develops from shortage of bile acids publication-title: J Lipid Res doi: 10.1194/jlr.S091199 – volume: 327 start-page: 965 issue: 10 year: 2022 ident: pone.0305170.ref005 article-title: Acute Cholecystitis: A Review publication-title: JAMA doi: 10.1001/jama.2022.2350 – volume: 14 start-page: 850 issue: 2 year: 2015 ident: pone.0305170.ref084 article-title: Profiling of serum bile acids in a healthy Chinese population using UPLC-MS/MS publication-title: Journal of proteome research doi: 10.1021/pr500920q – volume: 23 start-page: 241 issue: 3 year: 2003 ident: pone.0305170.ref048 article-title: A study on the relationship of the change of bile acids composing and the level of free Ca2+ gallbladder bile of patients with gallstones publication-title: Acta Academiae Medicinae Nantong – volume: 17 start-page: 5 issue: 1 year: 2005 ident: pone.0305170.ref047 article-title: Changes of the hepatocyte bile acid secretion in patients with gallstone publication-title: Journal of Hepatopancreatobiliary Surgery – volume: 13 start-page: 157 issue: 2 year: 2019 ident: pone.0305170.ref009 article-title: Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention publication-title: Expert Rev Gastroenterol Hepatol doi: 10.1080/17474124.2019.1549988 – volume: 7 start-page: 874 issue: 6 year: 2015 ident: pone.0305170.ref031 article-title: Interactions between the intestinal microbiota and bile acids in gallstones patients publication-title: Environmental microbiology reports doi: 10.1111/1758-2229.12319 – volume: 10 start-page: e0051822 issue: 5 year: 2022 ident: pone.0305170.ref076 article-title: FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains publication-title: Microbiology spectrum doi: 10.1128/spectrum.00518-22 – volume: 319 start-page: G303 issue: 3 year: 2020 ident: pone.0305170.ref019 article-title: Reabsorption of bile acids regulated by FXR-OATP1A2 is the main factor for the formation of cholesterol gallstone publication-title: American Journal of Physiology-Gastrointestinal and Liver Physiology doi: 10.1152/ajpgi.00385.2019 – volume: 111 start-page: 765 issue: 3 year: 1996 ident: pone.0305170.ref013 article-title: Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence publication-title: Gastroenterology doi: 10.1053/gast.1996.v111.pm8780583 – start-page: 513 issue: 09 year: 1992 ident: pone.0305170.ref053 article-title: Analysis of bile acids in patients with cholelithiasis by reversed-phase high performance liquid chromatographic publication-title: Shanghai Medical Journal – volume: 59 start-page: 269 issue: 3 year: 1999 ident: pone.0305170.ref034 article-title: Fecal bile acid excretion profile in gallstone patients publication-title: Medicina – ident: pone.0305170.ref055 – volume: 319 start-page: G619 issue: 5 year: 2020 ident: pone.0305170.ref074 article-title: Metabolic consequences of ileal interruption of the enterohepatic circulation of bile acids publication-title: American journal of physiology Gastrointestinal and liver physiology doi: 10.1152/ajpgi.00308.2020 – volume: 17 start-page: 629 issue: 6 year: 2005 ident: pone.0305170.ref014 article-title: Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/00042737-200506000-00007 – volume: 11 start-page: 12 year: 2020 ident: pone.0305170.ref017 article-title: Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver-Gut Axis publication-title: Front Pharmacol doi: 10.3389/fphar.2020.00012 – volume: 278 start-page: 2563 issue: 4 year: 2003 ident: pone.0305170.ref083 article-title: The farnesoid X-receptor is an essential regulator of cholesterol homeostasis publication-title: J Biol Chem doi: 10.1074/jbc.M209525200 – volume: 7 issue: 1 year: 2019 ident: pone.0305170.ref030 article-title: The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile publication-title: Microbiome doi: 10.1186/s40168-019-0712-8 – volume: 51 start-page: 706 issue: 7–9 year: 2016 ident: pone.0305170.ref020 article-title: Amphiphilic metabolites in gallbladder bile: Potential biomarkers for gallbladder diseases publication-title: Applied Spectroscopy Reviews doi: 10.1080/05704928.2016.1167707 – volume: 11 start-page: 641 issue: 5 year: 2020 ident: pone.0305170.ref023 article-title: Optimally estimating the sample standard deviation from the five-number summary publication-title: Res Synth Methods doi: 10.1002/jrsm.1429 – volume: 9 start-page: 164 year: 2011 ident: pone.0305170.ref007 article-title: Risk factors of gallbladder cancer in Karachi-a case-control study publication-title: World J Surg Oncol doi: 10.1186/1477-7819-9-164 – volume: 46 start-page: 1664 issue: 5 year: 2007 ident: pone.0305170.ref063 article-title: Changes in bile acid synthesis in gallstone disease: cause, consequence, or neither? publication-title: Hepatology doi: 10.1002/hep.21942 |
| SSID | ssj0053866 |
| Score | 2.4643176 |
| SecondaryResourceType | review_article |
| Snippet | The profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern. This study... Background The profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern.... BackgroundThe profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern.... Background The profiles of bile acids (BAs) in patients with gallstone disease (GSD) have been found to be altered markedly though in an inconsistent pattern.... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0305170 |
| SubjectTerms | Bile Bile acids Bile Acids and Salts - blood Bile Acids and Salts - metabolism Biological markers Biology and Life Sciences Biomarkers Biomarkers - blood Biomarkers - metabolism Calculi California China Cholecystectomy Cholesterol Chromatography Comparative analysis Deoxycholic acid Diseases Gallbladder Gallbladder diseases Gallstones Gallstones - blood Gallstones - metabolism Homeostasis Humans Inclusion Longitudinal studies Mass spectrometry Mass spectroscopy Medicine and Health Sciences Meta-analysis Metabolism Metabolites NMR Nuclear magnetic resonance Pain Patients People and Places Physical Sciences Qualitative analysis Research and Analysis Methods Scientific imaging Statistical methods Systematic review Taurocholic acid |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBAgYhAYe0duw4NrcFURUkQAKKeoscP8pKJbtqdv8_M4k3bFClcuAaTx47L39ez3wm5AWTtmBVEfOyqmIupXC5VTbkgWnA1zEKzrFR-NNndXIqP56VZztHfWFN2EAPPCjuyMhGN9IKFjRM3Uw1ZdSschLC0ho58HzCnLddTA05GKJYqdQoJyp-lOxyuFq24RBdnOPhxDsTUc_XP2bl2epi2V0FOf-unNyZio5vk1sJQ9L58O175EZo75C9FKUdfZWopF_fJcjQ5Bd9SqNI6x3oMtIGEgG1buE7ajv6K6zBD7ATmWIrPlbrXHYUoCzFPXmEhoGmXZw3dE7_MD_ToeuF2tb3D8lt4je5R06P339_d5KncxZyp4xY51r5WMamhGAvPABEIxT3rOFV9NEXzkQLazJuvAnOWxG4V2VjmGxYZVhgNoj7ZNbC1-wTyrUJXmmjC9FIZ4ItpItCe6u1E5b7jIit0muXSMjxLIyLut9Zq2AxMuiwRlPVyVQZyce7VgMJxzXyb9GeoyxSaPcXwLHq5Fj1dY6VkafoDfXQjzomgnquASYapZXOyPNeAmk0WqzTObebrqs_fPnxD0Lfvk6EXiahuAR1OJt6I-A3IT3XRPJgIgnJwE2G99F3t1rpasEQfsC6XsGdW3--evjZOIwPxdq7Niw3SaYSgPsz8mBw_1GzwiBfkID36klgTFQ_HWkXP3sWcwD6FaBR8fB_GOsRuVkA2sQ_3YvygMzWl5vwGNDiunnSJ4bfN7FpaA priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZguXBBlFeXFjAICTikdWLHsbmgBVEVJEACivYWOX6UlUqy3ez-f2YSb9qgCriuJ9lkXvlsz3wm5DkTJmNFFpK8KEIiBLeJkcYnninA1yHwNMVG4U-f5fGJ-DjP53HBrY1llduc2CVq11hcIz_kDPMoTFDkm-V5gqdG4e5qPELjOrmB1GVY0lXMhwkXxLKUsV2OF-lhtM7Bsqn9ATp6ikcUX_ocdaz9Q26eLM-a9irg-Wf95KUP0tFtcisiSTrrTb9Drvn6DtmJsdrSl5FQ-tVdgjxNbtElNork3p42gVaQDqixC9dS09Jffg3egP3IFBvysWZn1VIAtBR35hEgehr3cl7TGb3gf6Z97ws1tetukpjIcnKPnBy9__7uOImnLSRWar5OlHQhD1UOIZ85gImay9SxKi2CCy6zOhiYmaXaaW-d4T51Mq80ExUrNPPMeH6fTGp4ml1CU6W9k0qrjFfCam8yYQNXzihluUndlPCt0ksbqcjxRIyzsttfK2BK0uuwRFOV0VRTkgxXLXsqjn_Iv0V7DrJIpN390KxOyxiXpRaVqoThzCtAhkxWeVCssAKyvtGC8Sl5gt5Q9l2pQzooZwrAopZKqil51kkgmUaN1TqnZtO25YcvP_5D6NvXkdCLKBQaUIc1sUMC3glJukaS-yNJSAl2NLyLvrvVSlteBA9cufXnq4efDsN4U6zAq32ziTIFB_Q_JQ969x80yzWyBnH4XzUKjJHqxyP14mfHZQ5wvwBMyh_-_bn2yM0M0CQuqmf5PpmsVxv_CNDgunrchfxvRmRhHQ priority: 102 providerName: ProQuest |
| Title | Predictive value of bile acids as metabolite biomarkers for gallstone disease: A systematic review and meta-analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39052638 https://www.proquest.com/docview/3084712106 https://www.proquest.com/docview/3084773566 https://pubmed.ncbi.nlm.nih.gov/PMC11271903 https://doaj.org/article/94b8b4a30e864406b5f807c4ddea9403 http://dx.doi.org/10.1371/journal.pone.0305170 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwELZG98ILYvxaYRSDkICHVE6cxDYSQt3UMpA20KCob5ET26NSSUvTSvDC385d6gaCioCXPNRntz3fnb-LfZ8JecxiHTERuSARwgVxzItAp9oGlknA187xMMRC4bPz9HQcv5kkkz2yvbPVK7DamdrhfVLj5az_9cu3l-DwL-pbG0S47dRfzEvbRwMOBSTx-7A2CXTVs7jZVwDvrncvEbUEacS4L6b70yitxarm9G8id2cxm1e7YOnvpyt_Wa5G18k1jzPpYGMYB2TPljfIgffkij71dNPPbhJkcTLTOuxRpP62dO5oDsGC6mJqKqor-tmuwFawWpliuT6e6FlWFOAuxX17hI-W-p2e53RAf7JD001lDNWlqQcJtOdAuUXGo-GHk9PA38UQFKniq0CmxiUuTyAgRAZApOJpaFgeCmeciQrlNORtoTLKFkZzG5o0yRWLcyYUs0xbfpt0Svg1h4SGUlmTSiUjnseFsjqKC8el0VIWXIemS_hW6VnhicrxvoxZVu--CUhYNjrMcKoyP1VdEjS9Fhuijr_IH-N8NrJIs11_MF9eZt5rMxXnMo81Z1YCbmRpnjjJRBHDmqBVzHiXPEBryDY1q02wyAYSoKRKZSq75FEtgVQbJZ7ludTrqspev_34D0LvL1pCT7yQm4M6Cu3rJ-A_IYVXS_KoJQkBo2g1H6LtbrVSZZwhRIHcP4WeW3ve3fywacZB8XxeaedrLyM45AZdcmdj_o1muUJOIQ7fK1uO0VJ9u6WcfqqZziEZEIBY-d3_nNx75GoE4BPfwUfJEemslmt7H8DjKu-RK2Ii4ClPQnyOXvXI_vHw_N1Fr34d06vjBT6_D38AhAR1Xw |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOcAFUV5dKNQgEHBI68SJYyMhVB5VSx9I0KK9BcePUqkkS7MV4k_xG5lJvGmDKuDS63qSTcbj8TfxzDeEPGapTlie-CjLcx-lKTeRFtpFjknA197zOMZC4Z1dsbGfvh9n4znya1YLg2mVM5_YOmpbG_xGvsoZ-lEIUMSryfcIu0bh6eqshUZnFlvu5w8I2ZqXm29hfp8kyfq7vTcbUegqEBmh-DSSwvrMlxmYdmIBDikuYsvKOPfW28QoryECiZVVzljNXWxFViqWlixXzDHtONz3ErkMGy_DFZWP-wAPfIcQoTyP5_FqsIaVSV25FVxYMbZEPrP9tV0C-r1gfnJUN-cB3T_zNc9sgOvXybWAXOlaZ2oLZM5VN8hC8A0NfRYIrJ_fJMgLZQ9bR0qRTNzR2tMS3A_V5tA2VDf0m5uC9WH9M0UCAMwROm4oAGiKmQAISB0NZ0cv6Bo95ZumXa0N1ZVtbxLpwKpyi-xfyDzcJvMVPM0iobFUzgqpZMLL1Cink9R4Lq2W0nAd2xHhM6UXJlCfYweOo6I9z8shBOp0WOBUFWGqRiTqr5p01B__kH-N89nLInF3-0N9fFAEP1CotJRlqjlzEpAoE2XmJctNCruMVinjI7KM1lB0VbC9-ynWJIBTJaSQI_KolUDyjgqzgw70SdMUmx8-_4fQp48DoadByNegDqNDRQa8E5KCDSSXBpLggsxgeBFtd6aVpjhdrHDlzJ7PH37YD-NNMeOvcvVJkMk5RBsjcqcz_16zXCFLEYf_lYOFMVD9cKQ6_Npyp0N4kQMG5nf__lzL5MrG3s52sb25u3WPXE0AyeIH_SRbIvPT4xN3H5DotHzQLn9Kvly0v_kN7Bmelg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkRAXRHl1oVCDQMAhrRMnjo2EUKFULYWCKEV7C44fpVJJlmYrxF_j1zGTeNMGVcCl1_Ukm4xnPs_EM58JechSnbA88VGW5z5KU24iLbSLHJMQX3vP4xgbhd_tiM299M04G8-RX7NeGCyrnGFiC9S2NviNfJUzxFFIUMSqD2URH9Y3Xky-R3iCFO60zo7T6Exk2_38Aelb83xrHeb6UZJsvP70ajMKJwxERig-jaSwPvNlBmaeWAiNFBexZWWce-ttYpTXkI3EyipnrOYutiIrFUtLlivmmHYc7nuBXMx5FqOP5eM-2QMcESK06vE8Xg2WsTKpK7eCThbj8cinlsL2xIB-XZifHNbNWUHvn7WbpxbDjavkSohi6VpndgtkzlXXyELAiYY-CWTWT68T5IiyBy2oUiQWd7T2tAQootoc2Ibqhn5zU7BE7IWmSAaA9UJHDYVgmmJVAAanjoZ9pGd0jZ5wT9Ou74bqyrY3iXRgWLlB9s5lHm6S-QqeZpHQWCpnhVQy4WVqlNNJajyXVktpuI7tiPCZ0gsTaNDxNI7Dot3byyEd6nRY4FQVYapGJOqvmnQ0IP-Qf4nz2csiiXf7Q320XwRMKFRayjLVnDkJUSkTZeYly00KK45WKeMjsozWUHQdsT0UFWsSAlUlpJAj8qCVQCKPCl1iXx83TbH1_vN_CO1-HAg9DkK-BnUYHboz4J2QIGwguTSQBDgyg-FFtN2ZVprixHHhypk9nz18vx_Gm2L1X-Xq4yADTiZA5lZn_r1muULGIg7_KweOMVD9cKQ6-NryqEOqkUM8zG___bmWySVAmuLt1s72HXI5gaAWv-0n2RKZnx4du7sQlE7Le633U_LlvOHmN0LPosw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictive+value+of+bile+acids+as+metabolite+biomarkers+for+gallstone+disease%3A+A+systematic+review+and+meta-analysis&rft.jtitle=PloS+one&rft.au=Han%2C+Xu&rft.au=Wang%2C+Juan&rft.au=Wu%2C+Yingnan&rft.au=Gu%2C+Hao&rft.date=2024-07-25&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=19&rft.issue=7&rft.spage=e0305170&rft_id=info:doi/10.1371%2Fjournal.pone.0305170&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_pone_0305170 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |